V. Samano

发表

A review of recent advances on process technologies for upgrading of heavy oils and residua

J. Ancheyta, M. Rana, V. Samano, 2007 .

Discovery of next generation inhibitors of HIV protease.

W. Kazmierski, V. Samano, A. Spaltenstein, 2005, Current topics in medicinal chemistry.

Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase.

R. Hamatake, Z. Hong, Shawn P. Williams, 2014, Journal of medicinal chemistry.

Nucleic acid and related compounds. 75. Synthesis and radical-induced ring-opening reactions of 2'-deoxyadenosine-2'-spirocyclopropane and its uridine analogs. Mechanistic probes for ribonucleotide reductases

V. Samano, M. Robins, 1992 .

Wikipedia on the CompTox Chemicals Dashboard: Connecting Resources to Enrich Public Chemical Data

A. Richard, I. Thillainadarajah, V. Samano, 2022, J. Chem. Inf. Model..

A BATCH REACTOR STUDY OF THE EFFECT OF DEASPHALTING ON HYDROTREATING OF HEAVY OIL

J. Ancheyta, F. Trejo, V. Samano, 2010 .

Synthesis of ultra-short-acting neuromuscular blocker GW 0430: a remarkably stereo- and regioselective synthesis of mixed tetrahydroisoquinolinium chlorofumarates.

J. A. Ray, R. Mook, V. Samano, 1999, Organic letters.

Photochemistry of nucleoside transport inhibitor 6-S-benzylated thiopurine ribonucleosides. Implications for a new class of photoaffinity labels

D. B. Rawlins, V. Samano, S. Fleming, 1992 .

Ribonucleotide Reductase Targets for Chemotherapy; Mechanistic Aspects and Biologically Active Agents

V. Samano, M. Robins, M. C. Samano, 1995 .

Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.

J. A. Ray, L. Shewchuk, A. Hassell, 2006, Bioorganic & medicinal chemistry letters.

S. Wnuk, V. Samano, M. Robins, 1997 .

Stereocontrolled synthesis of cis-dibenzoquinolizine chlorofumarates: curare-like agents of ultrashort duration.

J. A. Ray, R. Mook, A. Sefler, 2001, The Journal of organic chemistry.

V. Samano, M. Robins, 1991 .

Efficient Conversion of 6-Aminopurines and Nucleosides into 6-Substituted Analogs via Novel 6-(1,2,4-Triazol-4-yl)purine Derivatives.

V. Samano, M. Robins, R. W. Miles, 1994 .

Binding of Cob(II)alamin to the adenosylcobalamin-dependent ribonucleotide reductase from Lactobacillus leichmannii. Identification of dimethylbenzimidazole as the axial ligand.

J. Stubbe, G. Gerfen, V. Samano, 1999, The Journal of biological chemistry.

Assembly and Curation of Lists of Per- and Polyfluoroalkyl Substances (PFAS) to Support Environmental Science Research

Linda G T Gaines, Charles N. Lowe, G. Patlewicz, 2022, Frontiers in Environmental Science.

2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.

J. G. Cory, V. Samano, M J Robins, 1994, Biochemical pharmacology.

Stereoselective Addition of a Wittig Reagent To Give a Single Nucleoside Oxaphosphetane Diastereoisomer. Synthesis of 2′(and 3′)-Deoxy-2′(and 3′)-methyleneuridine (and cytidine) Derivatives from Uridine Ketonucleosides

V. Samano, M. Robins, 1991 .

Mark D. Johnson, V. Samano, M. Robins, 1990 .

V. Samano, M. Robins, 1990 .

Synthesis of 3'-deoxyadenosine-3'-spirocyclopropane, 3'-deoxy-uridine-3'-spirocyclopropane, and 5'-deoxy-4',5'-methanoadenosine

V. Samano, M. Robins, 1994 .

V. Samano, M. D. Johnson, M. Robins, 1990 .

V. Samano, M. Robins, 1994 .

V. Samano, M. Robins, 1991 .

Preclinical Pharmacology of GW280430A (AV430A) in the Rhesus Monkey and in the Cat: A Comparison with Mivacurium

Sanjay S. Patel, R. Mook, T. Spitzer, 2004, Anesthesiology.

Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.

Sanjay S. Patel, J. A. Ray, R. Mook, 2003, Journal of medicinal chemistry.

Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting nondepolarizing neuromuscular blockers.

J. A. Ray, R. Mook, V. Samano, 1999, Journal of medicinal chemistry.

Revisiting the importance of appropriate parameter estimation based on sensitivity analysis for developing kinetic models

J. Ancheyta, G. Félix, V. Samano, 2020 .

Cracking of Maya Crude Asphaltenes

J. Ancheyta, F. Trejo, V. Samano, 2014 .

Pyrazolopyridine antiherpetics: SAR of C2' and C7 amine substituents.

J. A. Ray, V. Samano, G. A. Freeman, 2005, Bioorganic & medicinal chemistry.

A New Procedure to ?3-Ketosteroids from 5-3-Ketosteroids

V. Samano, J. Hernández, Victoria Valdes, 1990 .

Efficient Asymmetric Synthesis of N-[(1R)-6-Chloro-2,3,4,9-tetrahydro-1H-carbazol-1-yl]-2-pyridinecarboxamide for Treatment of Human Papillomavirus Infections

D. E. Patterson, R. Matsuoka, V. Samano, 2007 .

Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 agonists.

S. Roller, J. Way, S. Ross, 2012, Journal of medicinal chemistry.

Binding of Cob(II)alamin to the Adenosylcobalamin-dependent Ribonucleotide Reductase fromLactobacillus leichmannii

J. Stubbe, G. Gerfen, V. Samano, 1999, The Journal of Biological Chemistry.

DNA Encoded Library Technology-based discovery, lead optimization and prodrug strategy toward structurally-unique indoleamine 2,3-dioxygenase (IDO1) inhibitors.

Zhengrong Zhu, John Miller, N. Prabhu, 2020, Journal of medicinal chemistry.

Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains.

J. A. Ray, M. Hanlon, E. Furfine, 2004, Bioorganic & medicinal chemistry letters.

P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.

J. A. Ray, L. Shewchuk, A. Hassell, 2005, Bioorganic & medicinal chemistry letters.

Aza-stilbenes as potent and selective c-RAF inhibitors.

K. Lackey, R. Hunter, Ronda G. Davis-Ward, 2006, Bioorganic & medicinal chemistry letters.

Changes in structural parameters of SARA fractions during heavy oil hydrocracking using dispersed catalysts

J. Ancheyta, G. Félix, Alexander Quitian, 2023, Fuel.

Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamides.

M. Hanlon, E. Furfine, A. Shu, 2004, Biochemistry.

Detection of a new substrate-derived radical during inactivation of ribonucleotide reductase from Escherichia coli by gemcitabine 5'-diphosphate.

J. Stubbe, L. Perez, W. Donk, 1998, Biochemistry.